Related Experiment Video
Updated: Aug 11, 2026
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
CADASIL: a critical look at a Notch disease
Angeliki Louvi1, Joseph F Arboleda-Velasquez, Spyros Artavanis-Tsakonas
1Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA.
Insights
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a rare brain disorder. This review explores Notch 3 mutations and their role in CADASIL pathobiology and vascular cognitive impairment.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a late-onset degenerative neurological disorder.
- CADASIL is primarily linked to mutations in the Notch 3 receptor gene, leading to vascular abnormalities.
Purpose of the Study:
- To review and evaluate existing literature on CADASIL.
- To assess experimental systems used to study CADASIL pathobiology and genetics.
- To improve understanding of Notch 3 receptor malfunction in CADASIL.
Main Methods:
- Literature review of CADASIL-related studies.
- Analysis of experimental models for CADASIL research.
- Evaluation of genetic and pathobiological data.
Main Results:
- Notch 3 mutations are strongly associated with CADASIL.
- Molecular mechanisms of Notch 3 malfunction in CADASIL remain incompletely understood.
- CADASIL serves as a model for studying vascular cognitive impairment.
Conclusions:
- Further research is needed to elucidate the precise molecular mechanisms underlying Notch 3 receptor dysfunction in CADASIL.
- A comprehensive understanding of CADASIL pathobiology is crucial for developing effective treatments.
- CADASIL research provides insights into the broader field of vascular cognitive impairment.
Abstract:
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a catastrophic late-onset syndrome which manifests itself mainly as a central nervous system degenerative disorder. CADASIL has been associated with mutations in the Notch 3 receptor which appear to cause, mainly, vascular abnormalities. Although more than a decade has passed since Notch 3 mutations were linked with this disease, we still do not have a good grasp on the molecular mechanisms underlying the CADASIL-associated Notch 3 receptor malfunction, nor do we understand many aspects of the CADASIL pathobiology. In this review, we discuss the CADASIL-related literature and attempt to evaluate the various experimental systems and approaches used to address what seems to be a paradigm for studying the pathobiology and genetics of vascular cognitive impairment.
Related Concept Videos
01:25Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations